Structure via PubChem · Public domain (PubChem)
tenatoprazole
Sign in to saveTenatoprazole is a proton pump inhibitor drug candidate that was undergoing clinical testing as a potential treatment for reflux oesophagitis and peptic ulcer as far back as 2003. The compound was invented by Mitsubishi Tanabe Pharma and was licensed to Negma Laboratories (part of Wockhardt as of 2007).
Chemical data
- Formula
- C16H18N4O3S
- Molecular weight
- 346.4 g/mol
- IUPAC name
- 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
- Indications
- peptic esophagitis
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 346.11
Show 3 more facts
- chemical formula
- C₁₆H₁₈N₄O₃S
- canonical SMILES
- CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=CC(=N3)OC
- Commons category
- Tenatoprazole
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Tenatoprazole is a proton pump inhibitor drug candidate that was undergoing clinical testing as a potential treatment for reflux oesophagitis and peptic ulcer as far back as 2003. The compound was invented by Mitsubishi Tanabe Pharma and was licensed to Negma Laboratories (part of Wockhardt as of 2007).
Mitsubishi reported that tenatoprazole was still in Phase I clinical trials in 2007 and again in 2012.
Excerpted from Wikipedia’s “tenatoprazole” article, available under the CC BY-SA 4.0 licence.
Available in 10 languages
via Wikidata sitelinks · CC0